Cardiff Oncology Announces First Patient Dosed in Randomized First-line RAS-mutated Metastatic Colorectal Cancer Trial (CRDF-004)
Stock Information for Hepion Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.